301 related articles for article (PubMed ID: 9177553)
1. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
Corp ES; Curcio M; Gibbs J; Smith GP
Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
Brenner LA; Ritter RC
Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
[TBL] [Abstract][Full Text] [Related]
3. Elevation of feed intake in parasite-infected lambs by central administration of a cholecystokinin receptor antagonist.
Dynes RA; Poppi DP; Barrell GK; Sykes AR
Br J Nutr; 1998 Jan; 79(1):47-54. PubMed ID: 9505802
[TBL] [Abstract][Full Text] [Related]
4. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
Ebenezer IS; Baldwin BA
Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
Lu L; Zhang B; Liu Z; Zhang Z
Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
[TBL] [Abstract][Full Text] [Related]
6. CCK is involved in both peripheral and central mechanisms controlling food intake in chickens.
Rodríguez-Sinovas A; Fernández E; Manteca X; Fernández AG; Goñalons E
Am J Physiol; 1997 Jan; 272(1 Pt 2):R334-40. PubMed ID: 9039026
[TBL] [Abstract][Full Text] [Related]
7. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
[TBL] [Abstract][Full Text] [Related]
8. The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats.
Eberle-Wang K; Simansky KJ
Pharmacol Biochem Behav; 1992 Nov; 43(3):943-7. PubMed ID: 1448490
[TBL] [Abstract][Full Text] [Related]
9. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
[TBL] [Abstract][Full Text] [Related]
11. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake.
Lo CM; Zhang DM; Pearson K; Ma L; Sun W; Sakai RR; Davidson WS; Liu M; Raybould HE; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1490-4. PubMed ID: 17634201
[TBL] [Abstract][Full Text] [Related]
12. Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice.
Hirosue Y; Inui A; Miura M; Nakajima M; Okita M; Himori N; Baba S; Kasuga M
Peptides; 1992; 13(1):155-7. PubMed ID: 1620653
[TBL] [Abstract][Full Text] [Related]
13. Intravenous infusion of CCKA-receptor antagonist increases food intake in rats.
Miesner J; Smith GP; Gibbs J; Tyrka A
Am J Physiol; 1992 Feb; 262(2 Pt 2):R216-9. PubMed ID: 1539728
[TBL] [Abstract][Full Text] [Related]
14. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
[TBL] [Abstract][Full Text] [Related]
15. Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists.
Murphy RB; Smith GP; Schneider LH; Gibbs J
Peptides; 1992; 13(1):77-81. PubMed ID: 1620660
[TBL] [Abstract][Full Text] [Related]
16. Proglumide fails to increase food intake after an ingested preload.
Schneider LH; Gibbs J; Smith GP
Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
Wang SX
Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
[TBL] [Abstract][Full Text] [Related]
18. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys.
Moran TH; Ameglio PJ; Peyton HJ; Schwartz GJ; McHugh PR
Am J Physiol; 1993 Sep; 265(3 Pt 2):R620-4. PubMed ID: 8214156
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
Millington WR; Mueller GP; Lavigne GJ
J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
[TBL] [Abstract][Full Text] [Related]
20. Effect of L364.718 during suckling on the sensitivity to the hypophagic effect of cholecystokinin in adult rats.
Voits M; Rödel S; Förster S; Plagemann A; Fink H
Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):183-92. PubMed ID: 9075266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
